ARCHIVES

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 29 No. 27 | July 4, 2003

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI

September 26, 2003

New Jersey Insurers To Cover Patient Care Costs In Trials.

January 14, 2000

FDA Issues Final Rules On Patient Access To Investigational Drugs

September 11, 2009

Three Institutions In Texas To Form Center For Childhood Cancer Epidemiology Research.

February 2, 2001

Intercultural Cancer Council Endorses New NCI Office

July 5, 1996

American cancer Society Funds 84 Research Grants. NCI, NIGMS To Support Synchrotron Beamlines.

November 16, 2001